NASDAQ Companies

SANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage […]

Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3 Prolonged survival […]

SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the […]

ARCHBOLD, Ohio, April 24, 2024 (GLOBE NEWSWIRE) — F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants […]

First quarter comparable store sales growth of 3.4% 11% increase in first quarter diluted earnings per share to $9.20 Completed […]

NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]

“First-to-Fiber” and “Glass & Steel™” Strategies Drive Continued Year-Over-Year Growth in High-Speed Data Subscribers and Network Reach First quarter revenues […]

LONDON and NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy […]

MATTOON, Ill., April 24, 2024 (GLOBE NEWSWIRE) — First Mid Bancshares, Inc. (NASDAQ: FMBH) (the “Company”) today announced its financial […]

First Quarter 2024 Highlights: Net Sales $738 Million; Conversion Revenue $367 Million Net Income $25 Million; Net Income per Diluted […]